Skip to content
Modern Today

Zimbabwe Turns Down ‘Lopsided’ US Health Aid Deal Due to Data Fears

Medical funding image
The offered US funding would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has turned down a significant US healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to Washington's request for confidential information.

The decision was revealed following a internal memorandum dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".

An official spokesperson has since stated that the United States was seeking genetic material for scientific study and commercial purposes while refused to share the resulting advantages from any future treatments.

"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy said the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has appealed for more dialogue to find a deal acceptable to all parties so the nation's critical HIV treatment initiative can be sustained.

Wider Background

Zimbabwe's decision comes after a comparable case in Kenya, where a court suspended a related health funding agreement after legal challenges were filed about the safety of citizens' medical information.

After returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

The agency had administered assistance for the US government, but Trump stated its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance transparency and responsibility.

Based on statements, 16 African countries have to date signed these new health pacts, representing more than $18.3bn in committed funds.

Specifics of the Declined Agreement

The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this partnership might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy via US-supported initiatives," Tremont commented.

However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".

"Our nation was requested to share its genetic material and health information for a long time, with no corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," Mangwana explained.

"Put simply, our nation would supply the basic resources for medical research without any assurance that the final treatments would be available to our citizens if a new disease outbreak arise."

Sovereignty and Global Health

Mangwana further said that the American exit from the global health body and its push of one-on-one deals were undermining systems previously established through the global health agency.

Mangwana cited its Pandemic Benefit-Sharing system designed to manage future pandemics.

"This mechanism is intended to guarantee that when a country contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to develop them."

Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We encourage continued dialogue with our US partners on how subsequent co-operation might be arranged in a way that honours the independence and interests of both nations."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that talks should continue since a large portion of the nation's Aids initiatives were funded by international support.

"If technical issues exist, including those relating to information security or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," the group said.

The halted deal underscores the ongoing challenges between accepting crucial international aid and safeguarding national sovereignty in an increasingly interconnected world.

TL
About the author

Tina Lewis

Alex Mercer is a digital journalist and content creator passionate about technology, culture, and modern living.

Modern Today

Type to search articles.